Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-28

Clinical Trial Update: Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot clinical trial evaluating slow-release Circadin melatonin for idiopathic REM sleep behavior disorder. The trial is sponsored by Seoul National Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Circadin (melatonin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: REM Sleep Behavior Disorder | Phase 4 | Status: UNKNOWN